Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Introduction
00:00 • 2min
The Monoma Mean Hypothesis
02:29 • 2min
The Role of Serotonin in Theology of MDD
04:04 • 3min
The Relationship Between Symptoms and MDD
06:42 • 2min
The Clinical Relevance of Antidepressants
08:41 • 4min
The Importance of Cognitive Scars
12:17 • 2min
The Role of Neurons in Major Depressive Disorder
14:18 • 2min
GABA and Glutamic Signaling in Depression
16:48 • 2min
The Role of GABA in Depression
19:12 • 3min
The Negative Cognitive Bias of Repeated Episodes
22:05 • 2min
The Effects of Psychedelics on Depression
24:03 • 2min
The Effects of Kappa Opioids on Depression
25:58 • 2min
The Effects of Zeranolone on GABAA Receptors
27:42 • 3min
The New Paradigm of Intermittent Treatment
30:54 • 2min
The Effects of Multimodal Agents on NMDA Receptors
32:57 • 2min
Dextromathorfen: A Novel Antidepressant
34:37 • 2min
The Effects of Texturmethorphin on Neurotransmitter Synthesis
36:34 • 2min
The Role of Neurosteroids in Cognition Learning Memory
38:53 • 3min
Ketamine and Eschitamine: A Comparison
41:32 • 4min
The Benefits of Racemic Ketamine
45:06 • 2min
The Role of Ketamine in the Treatment of Depression
47:01 • 3min
Psychedelics: What We Know So Far
49:52 • 2min
The Role of Psychedelics in Brain Network Strength
52:21 • 2min
The Paradigm Shift in Psychopharmacology
54:10 • 3min
The Role of Physical Activity in Depression
57:37 • 2min
The Importance of Epigenetic Testing in Antidepressants
59:12 • 3min
The Role of Genes in Antidepressants
01:01:59 • 2min
The Importance of Knowledge Transfer
01:04:07 • 2min